-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, COnclsO5JbNLr7FzrBF5WbTfY5RxYLdCOrCTFry+jvm9H+ZtB7tqChKLejfxU7Or 62ROEAQqAWlKbu+3MQtzgg== 0000849043-05-000164.txt : 20051216 0000849043-05-000164.hdr.sgml : 20051216 20051216165126 ACCESSION NUMBER: 0000849043-05-000164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20051215 FILED AS OF DATE: 20051216 DATE AS OF CHANGE: 20051216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER FELIX CENTRAL INDEX KEY: 0001087940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 051270263 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 2125212420 MAIL ADDRESS: STREET 1: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-12-15 0000849043 NEUROGEN CORP NRGN 0001087940 BAKER FELIX 35 NE INDUSTRIAL RD. BRANFORD CT 06405 1 0 1 0 Stock Options (Right to Buy) 8.40 2005-12-15 4 A 0 2500 A 2015-12-15 Common Stock 2500 2500 D Pursuant to the Neurogen Corporation 2000 Non-Employee Directors Stock Option Program, the options will vest in three (3) monthly installments on the last day of each month, beginning the last day of the month in which such option was granted. The option was granted under the Neurogen Corporation 2000 Non-Employee Directors Stock Option Program, for no consideration. Stephen Davis, Attorney-in-fact 2005-12-16 EX-24 2 fbaker.htm POWER OF ATTORNEY 
                  POWER OF ATTORNEY









 The undersigned hereby appoints Stephen R. Davis, EVP

and Chief Business Officer of Neurogen Corporation, his or her

attorney-in-fact and agent in any and all capacities to execute

for and on his or her behalf filings with the Securities and

Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the

extent that such filings relate to the undersigned's status as

a director or officer of Neurogen Corporation.  The undersigned

further appoints Stephen R. Davis his or her attorneyin fact

and agent to execute any and all amendments to such filings as

such attorney-in-fact and agent deems appropriate.  The

undersigned hereby grants to such attorney-in-fact and agent

full power and authority to do and perform each and every act

necessary or desirable as the undersigned could do in person,

hereby ratifying and confirming all that such attorney in fact

and agent may lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of July 21, 2003.





/s/ FELIX BAKER

_____________________________

Felix Baker
-----END PRIVACY-ENHANCED MESSAGE-----